Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04566302 · ClinicalTrials.gov registry record · NA
Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT04566302: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04566302 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04566302, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate the imaging performance of Spectrally Encoded Confocal Microscopy (SECM) for imaging human skin and skin diseases.
Interventions
- DEVICE SECM Skin Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2021-10-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04566302
The ClinicalTrials.gov registry entry for NCT04566302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SECM Skin Imaging is the first listed.
NCT04566302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04566302 about?
NCT04566302 is a clinical study titled "Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy". The aim of this study is to evaluate the imaging performance of Spectrally Encoded Confocal Microscopy (SECM) for imaging human skin and skin diseases.
What is the current status of trial NCT04566302?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-07-19. Estimated completion is 2021-10-22.
What interventions are being tested in trial NCT04566302?
The interventions under investigation include: SECM Skin Imaging (DEVICE).
Who is sponsoring clinical trial NCT04566302?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.